Vimarsana
Biggest News Aggregation in the World

Page 6 - Cancer Database News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cancer Database. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cancer Database Today - Breaking & Trending Today

Income, Education Linked to Advanced Stage of Diagnosis of NSCLC - Vimarsana News

Income, Education Linked to Advanced Stage of Diagnosis of NSCLC

MONDAY, June 20, 2022 (HealthDay News) -- Area-level income and education are associated with the diagnosis of non-small cell lung cancer (NSCLC) at an advanced stage, according to a study

Source: psu.edu
Black, Hispanic patients with advanced liver cancer have lower chance of receiving immunotherapy - Vimarsana News

Black, Hispanic patients with advanced liver cancer have lower chance of receiving immunotherapy

Racial and ethnic minorities diagnosed with advanced liver cancer have a lower chance of receiving immunotherapy, the most effective treatment for patients with the disease, according to a new study led by Cedars-Sinai Cancer investigators.

Black and Hispanic Patients Less Likely To Receive Lifesaving Immunotherapy - Vimarsana News

Black and Hispanic Patients Less Likely To Receive Lifesaving Immunotherapy

A review of medical records has revealed racial disparities in patients receiving immunotherapy to treat stage 3 or 4 liver cancer.

Post-RC Radiation Does Not Up Survival in Locally Advanced Bladder Cancer - Vimarsana News

Post-RC Radiation Does Not Up Survival in Locally Advanced Bladder Cancer

The addition of radiation therapy to adjuvant chemotherapy after radical cystectomy for bladder cancer does not appear to prolong survival.

Black vs White Race Tied to Worse Survival in Renal Cell Carcinoma - Vimarsana News

Black vs White Race Tied to Worse Survival in Renal Cell Carcinoma

Investigating the racial disparities in survival after renal cell carcinoma diagnosis is challenging and leaves outstanding questions.